Li Zhu
No. 100 Haining Road
Hongkou, 200080, China
Hongkou, 200080, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Oncological outcome of endoscopic nipple-sparing mastectomy versus conventional open mastectomy in early breast cancer: a multicenter cohort study.
Journal: World journal of surgical oncology
Published: May 17, 2026
Impact of clinicopathological factors on extended endocrine therapy decision making in estrogen receptor-positive breast cancer.
Journal: Frontiers in oncology
Published: July 17, 2022
Prognostic values of clinical and molecular features in HER2 low-breast cancer with hormonal receptor overexpression: features of HER2-low breast cancer.
Journal: Breast cancer (Tokyo, Japan)
Published: February 07, 2022
Perceived Importance of Breast Cancer Risk Factors: A Survey on 386 Physicians in China.
Journal: Asian Pacific journal of cancer prevention : APJCP
Published: December 27, 2021
Impact of Different Modules of 21-Gene Assay in Early Breast Cancer Patients.
Journal: Frontiers in endocrinology
Published: August 16, 2021
Identification of a novel immune-related prognostic signature associated with tumor microenvironment for breast cancer.
Journal: International immunopharmacology
Published: March 22, 2021
Efficacy of adjuvant chemotherapy stratified by age and the 21-gene recurrence score in estrogen receptor-positive breast cancer.
Journal: BMC cancer
Published: February 28, 2021
Combined Estrogen Receptor and Progesterone Receptor Level Can Predict Survival Outcome in Human Epidermal Growth Factor Receptor 2-positive Early Breast Cancer.
Journal: Clinical breast cancer
Published: December 28, 2020
Clinical characteristics and disease outcomes in ER+ breast cancer: a comparison between HER2+ patients treated with trastuzumab and HER2- patients.
Journal: BMC cancer
Published: November 27, 2020
A nomogram to predict the high-risk RS in HR+/HER2-breast cancer patients older than 50 years of age.
Journal: Journal of translational medicine
Published: October 11, 2020
HER2 positivity is not associated with adverse prognosis in high-risk estrogen receptor-positive early breast cancer patients treated with chemotherapy and trastuzumab.
Journal: Breast (Edinburgh, Scotland)
Published: May 22, 2020
Biomarkers of Insulin and the Insulin-Like Growth Factor Axis in Relation to Breast Cancer Risk in Chinese Women.
Journal: OncoTargets and therapy
Published: April 15, 2020
Last Updated: 09/26/2026